Cargando…
The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments
SIMPLE SUMMARY: During the development and progression of lung tumors, processes such as necrosis and vascular invasion shed tumor cells or cellular components into various fluid compartments. Liquid biopsies consist of obtaining a bodily fluid, typically peripheral blood, in order to isolate and in...
Autores principales: | Di Capua, Daniel, Bracken-Clarke, Dara, Ronan, Karine, Baird, Anne-Marie, Finn, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391249/ https://www.ncbi.nlm.nih.gov/pubmed/34439082 http://dx.doi.org/10.3390/cancers13163923 |
Ejemplares similares
-
Liquid Biopsies in the Clinical Management of Germ Cell Tumor Patients: State-of-the-Art and Future Directions
por: Lobo, João, et al.
Publicado: (2021) -
Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise
por: Healey Bird, Brian, et al.
Publicado: (2022) -
Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019) -
Liquid Biopsy in Diagnosis and Prognosis of High-Grade Gliomas; State-of-the-Art and Literature Review
por: Bonosi, Lapo, et al.
Publicado: (2022) -
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies
por: Lim, Marvin C. J., et al.
Publicado: (2018)